RZB | Ticker Profile - Titan Protect

RZB

Reinsurance Group of America, Incorporated

· · NYQ

$25.32

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

MODERATE

Data Confidence: 71.4%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

N/A

Total market value of the company

Trailing P/E

4.15

Very cheap relative to earnings

Forward P/E

N/A

Based on estimated future earnings — lower means cheaper

Rev Growth

+23.5%

Year-over-year revenue change

Profit Margin

4.9%

How much profit the company keeps from each dollar of revenue

ROE

9.9%

Return on equity — how efficiently it uses shareholder money

Analyst Target

N/A

Recommendation

NONE

Consensus view from ? analysts covering this stock

About Reinsurance Group of America, Incorporated

Reinsurance Group of America, Incorporated provides life and health, and asset-intensive reinsurance in the United States, Latin America, Canada, Europe, the Middle East, Africa, Asia, and Australia. It offers individual and group life and health, disability, long-term care, and critical illness reinsurance; and financial solutions, such as asset-intensive reinsurance, longevity reinsurance, stable value products, pension risk transfer transactions, and capital solutions. The company also provides reinsurance for mortality, morbidity, lapse, and investment-related risks; coinsurance of payout annuities; underwritten annuities; funding agreement backed note program and other capital motivated solutions; and superannuation. Reinsurance Group of America, Incorporated was founded in 1973 and is headquartered in Chesterfield, Missouri.

https://www.rgare.com

Country: United States Employees: 4,300

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

1.425

Excellent risk-adjusted returns

Kelly Fraction

0.0333

Modest edge detected — smaller position warranted

Calmar Ratio

2.429

Returns exceed worst-case losses — strong risk profile

Annual Return

6.3%

Historical annualised return based on price data

Max Drawdown

-2.6%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.50

Very low correlation to market moves

52W High

$25.38

0% below the year high

52W Low

$24.42

4% above the year low

Avg Volume

102,357

Average daily shares traded — higher means easier to buy and sell

Short Ratio

N/A

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$6.09

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

45.61

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.12

Adequate but worth monitoring

Quick Ratio

0.60

Like current ratio but excludes inventory — stricter test

Gross Margin

13.5%

Revenue left after cost of goods — higher means pricing power

Operating Margin

8.3%

Profit from core operations before interest and tax

Free Cash Flow

$4.8B

Positive — the business generates more cash than it spends

Revenue (TTM)

$24.9B

Total revenue over the last 12 months

Net Income

$1.2B

Profitable — the bottom line is positive

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go